Farallon Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $166M | Sell |
|
|||||
|
2023
Q2 | $198M | Sell |
|
|||||
|
2023
Q1 | $310M | Buy |
|
|||||
|
2022
Q4 | $325M | Sell |
|
|||||
|
2022
Q3 | $364M | Sell |
|
|||||
|
2022
Q2 | $399M | Buy |
|
|||||
|
2022
Q1 | $378M | Buy |
|
|||||
|
2021
Q4 | $350M | Sell |
|
|||||
|
2021
Q3 | $319M | Buy |
|
|||||
|
2021
Q2 | $248M | Sell |
|
|||||
|
2021
Q1 | $296M | Sell |
|
|||||
|
2020
Q4 | $409M | Hold |
|
|||||
|
2020
Q3 | $342M | Buy |
|
|||||
|
2020
Q2 | $329M | Hold |
|
|||||
|
2020
Q1 | $284M | Hold |
|
|||||
|
2019
Q4 | $378M | Buy |
|
|||||
|
2019
Q3 | $255M | Buy |
|
|||||
|
2019
Q2 | $296M | Buy |
|
|||||
|
2019
Q1 | $237M | Sell |
|
|||||
|
2018
Q4 | $276M | Buy |
|
|||||
|
2018
Q3 | $284M | Hold |
|
|||||
|
2018
Q2 | $246M | Buy |
|
|||||
|
2018
Q1 | $218M | Buy |
|
|||||
|
2017
Q4 | $185M | Buy |
|
|||||
|
2017
Q3 | $39.9M | Hold |
|
|||||
|
2017
Q2 | $39.5M | Buy |
|